CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 9 enrolled
Drug / intervention
Ankle resistance and biofeedbackdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06284525
NCT06284525Early Ph 1Completed

Ankle Assistance and Resistance in Older Adults

Northern Arizona University·interventional·Posted Feb 29, 2024·Updated Oct 1, 2025

In Brief

A Early Phase 1 clinical trial evaluating Ankle resistance and biofeedback for Sarcopenia. Completed, enrolled 9 participants across 1 site.

Detailed Summary

The goal of this research protocol is to improve mobility in older individuals through advances in wearable assistive devices by focusing on two specific aims. The first aim is to study if targeted ankle resistance gait training improves walking performance in older individuals. The second aim is to evaluate the potential of wearable assistance at the ankle, knee, and/or hip joints to increase walking performance in older individuals.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSarcopenia
CountriesUnited States
Collaborators--

Timeline

Early Ph 1CompletedFinished
2023202420252026
First PostedFeb 29, 2024
Enrollment StartFeb 1, 2023
Primary CompletionFeb 20, 2024
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 2.3 years ago

Interventions

Ankle resistance and biofeedbackdevice

An ankle exoskeleton will provide stance phase resistance and a plantar pressure biofeedback system will encourage late stance push-off.